BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 35047245)

  • 1. Outcomes of Gamma Knife Radiosurgery for Brain Metastases From Anaplastic Lymphoma Kinase Rearrangement-Positive and EGFR Mutation-Positive Non-Small Cell Lung Cancer.
    Matsunaga S; Shuto T
    Cureus; 2021 Dec; 13(12):e20398. PubMed ID: 35047245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma Knife radiosurgery for metastatic brain tumors from ovarian cancer: histopathological analysis of survival and local control. A Japanese multi-institutional cooperative and retrospective cohort study.
    Matsunaga S; Shuto T; Serizawa T; Aoyagi K; Hasegawa T; Kawagishi J; Yomo S; Kenai H; Nakazaki K; Moriki A; Iwai Y; Yamamoto T
    J Neurosurg; 2022 Oct; 137(4):1006-1014. PubMed ID: 35148503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non-small cell lung cancer and brain metastases.
    Lee CC; Hsu SPC; Lin CJ; Wu HM; Chen YW; Luo YH; Chiang CL; Hu YS; Chung WY; Shiau CY; Guo WY; Hung-Chi Pan D; Yang HC
    J Neurosurg; 2019 Jun; 133(2):313-320. PubMed ID: 31226692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
    Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
    J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?
    Wang TJ; Saad S; Qureshi YH; Jani A; Nanda T; Yaeh AM; Rozenblat T; Sisti MB; Bruce JN; McKhann GM; Lesser J; Halmos B; Stoopler MB; Lassman AB; Cheng SK; Isaacson SR
    Neuro Oncol; 2015 Jul; 17(7):1022-8. PubMed ID: 25910841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases.
    Liao HR; Chiang CL; Shen CI; Chen CJ; Yang HC; Wu HM; Luo YH; Hu YS; Lin CJ; Chung WY; Shiau CY; Guo WY; Pan DH; Lee CC
    J Neurooncol; 2022 Sep; 159(3):675-684. PubMed ID: 35976545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
    Kawabe T; Yamamoto M; Sato Y; Yomo S; Kondoh T; Nagano O; Serizawa T; Tsugawa T; Okamoto H; Akabane A; Aita K; Sato M; Jokura H; Kawagishi J; Shuto T; Kawai H; Moriki A; Kenai H; Iwai Y; Gondo M; Hasegawa T; Yasuda S; Kikuchi Y; Nagatomo Y; Watanabe S; Hashimoto N
    J Neurosurg; 2016 Dec; 125(Suppl 1):11-17. PubMed ID: 27903179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.
    Balasubramanian SK; Sharma M; Venur VA; Schmitt P; Kotecha R; Chao ST; Suh JH; Angelov L; Mohammadi AM; Vogelbaum MA; Barnett GH; Jia X; Pennell NA; Ahluwalia MS
    Neuro Oncol; 2020 Feb; 22(2):267-277. PubMed ID: 31648302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Cancer of Unknown Primary.
    Matsunaga S; Shuto T; Kobayashi N
    World Neurosurg; 2019 Feb; 122():e1465-e1471. PubMed ID: 30468925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery.
    Lee MH; Kong DS; Seol HJ; Nam DH; Lee JI
    J Korean Neurosurg Soc; 2017 Jan; 60(1):21-29. PubMed ID: 28061489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Epidermal Growth Factor Receptor Mutation on Intracranial Progression-Free Survival of Non-Small Cell Lung Cancer Patients with Brain Metastasis Underwent Gamma Knife Radiosurgery.
    Yang SH; Kim HY; Lee SI; Jin SJ
    Brain Tumor Res Treat; 2020 Oct; 8(2):103-108. PubMed ID: 33118342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501).
    Matsunaga S; Shuto T; Yamamoto M; Yomo S; Kondoh T; Kobayashi T; Sato M; Okamoto H; Serizawa T; Nagano O; Kenai H; Obara T; Iwai Y; Yasuda S; Hasegawa T; Kubo K; Shidoh S; Mori K; Hayashi M; Inoue A; Onoue S; Gondo M
    Stereotact Funct Neurosurg; 2018; 96(3):162-171. PubMed ID: 29969770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
    Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
    Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma Knife radiosurgery for intracranial benign meningiomas: follow-up outcome in 130 patients.
    Ge Y; Liu D; Zhang Z; Li Y; Lin Y; Wang G; Zong Y; Liu E
    Neurosurg Focus; 2019 Jun; 46(6):E7. PubMed ID: 31153153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome in gamma knife radiosurgery for metastatic brain tumors from the primary breast cancer : prognostic factors in local treatment failure and survival.
    Choi SW; Kwon DH; Kim CJ
    J Korean Neurosurg Soc; 2013 Oct; 54(4):329-35. PubMed ID: 24294457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau].
    Lin YP; Li Q; Ma LY; Liu X; Dai M; Wang XX; Li HS; Liu JX; Shen ZH; Guo YJ; Du YX; Yang RJ; Huang YC; Zhou YC
    Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):735-740. PubMed ID: 32988155
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer.
    Na YC; Jung HH; Kim HR; Cho BC; Chang JW; Park YG; Chang WS
    J Neurooncol; 2017 Apr; 132(2):333-340. PubMed ID: 28074321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Uterine Cervical and Endometrial Carcinomas: Histopathological Analysis of Survival and Local Control. A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study.
    Matsunaga S; Shuto T; Serizawa T; Aoyagi K; Hasegawa T; Kawagishi J; Yomo S; Kenai H; Nakazaki K; Moriki A; Iwai Y; Yamanaka K; Yamamoto T
    World Neurosurg; 2023 Mar; 171():e572-e580. PubMed ID: 36529429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases.
    Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Suh JH; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Chao ST
    Pract Radiat Oncol; 2017; 7(4):e263-e273. PubMed ID: 28254368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Single-Institution Analysis of 126 Patients Treated with Stereotactic Radiosurgery for Brain Metastases.
    Harris KB; Corbett MR; Mascarenhas H; Lee KS; Arastu H; Leinweber C; Ju AW
    Front Oncol; 2017; 7():90. PubMed ID: 28553615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.